1HOWELL D S,MUI.LER F,MANICOURT D H. A mini review: proteoglycan aggregate profiles in the pondnnki dog model of osteoarthritis and in canine disuse atrophy[J]. Br J Rheumatol,1992,31:7-9.
2PEYRON J G,BALAZS E A. Preliminary clinical assessment of nahyaluronate injection into human arthritic joint[J]. Pathol Biol,1974,22:731-733.
3BAI.AZS E A, DENLINGER J L. Viscosupplementation: a new concept in the treatment of osteoarthritis [J ]. J Rheum, 1993,39:3-9.
4FORSTER M C,STRAW R. A prospective randomized trial comparing intra-articular hyalgan injection and arthroscopic washout for knee osteoarthritis[J].Knee,2003,10:291-293.
5STOVE J,GERLACH C,HUCH K,et al. Effects of hyaluronan on proteoglycan content of osteoarthritic chondrocytes in vitro [J]. J Orthop Rex,2002,20:551-555.
6TASCIOTAOGLU F,ONER C. Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis[J]. Clin Rheumatol, 2003,22 : 112-117.
7WEN D Y. Intra articular hyaluronic acid injections for knee osteoarthritis[J]. Am Fam Physician,2000,62:565-570.
8GHOSH P, GUIDOLIN D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis:are the effects molecular weight dependent [J]. Semin Arthritis Rheum, 2002,32:10-37.
5Honig S. Osteoporosis-new treatments and updates [ J ]. Bull NYU Hosp Jt Dis. 2010, 68 (3) : 166-170.
6Griffith L, Raina P, Wu H, et al. Population attributable risk for functional disability associated with chronic conditions in Canadian older aduhs[J]. Age Ageing. 2010, 39 (6) : 738- 745.
7宇妥·元丹贡布.四部医典[M].台北:元气斋出版社,2004.336-339.
8占堆,赵军宁.藏医成方制剂[M].成都:四川科学技术出版社.2009:566-571.
9Honig S. Osteoporosis-new treatments and updates[J].Bull NYU Hosp Jt Dis,2010.166-170.
10Griffith L,Raina P,Wu H. Population attributable risk for functional disability associated with chronic conditions in Canadian older adults[J].Age and Ageing,2010.738-745.
